K. Pallier

发表

Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.

P. Laurent-Puig, A. Griffiths, H. Blons, 2013, Clinical chemistry.

Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples.

P. Laurent-Puig, A. Cazes, H. Blons, 2012, Experimental and molecular pathology.

How apoptosis and epithelial-to-mesenchymal transition are nested in EGFR inhibitors resistance in lung cancer.

E. Garelli, H. Blons, S. Garinet, 2019, Journal of thoracic disease.

TWIST1 a New Determinant of Epithelial to Mesenchymal Transition in EGFR Mutated Lung Adenocarcinoma

P. Laurent-Puig, A. Cazes, M. Riquet, 2012, PloS one.

Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma

P. Laurent-Puig, P. Dessen, M. Riquet, 2008, BMC Medical Genomics.

No somatic genetic change in the paxillin gene in nonsmall‐cell lung cancer

P. Laurent-Puig, A. Cazes, H. Blons, 2009, Molecular carcinogenesis.

Antiviral and cytotoxic activities of α-methylideneglycurononitriles and nucleosides thereof

J. Tronchet, K. Pallier, G. Werner, 1986 .

DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma

Pierre Laurent-Puig, Cristina Lecchi, Aurélie Cazes, 2012, Tumor Biology.

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer

S. Imbeaud, P. Laurent-Puig, H. Blons, 2017, Cancers.

[p16: molecular mechanisms involved in the carcinogenesis of various organs].

P. Laurent-Puig, H. Blons, K. Pallier, 2010, Annales de pathologie.

Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer

Pierre Laurent-Puig, Françoise Le Pimpec-Barthes, Diane Damotte, 2015, Oncotarget.

Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2013, International journal of cancer.

Histologic subtypes, immunohistochemistry, FISH or molecular screening for the accurate diagnosis of ALK-rearrangement in lung cancer: a comprehensive study of Caucasian non-smokers.

P. Laurent-Puig, A. Cazes, H. Blons, 2012, Lung cancer.

ERBB2 gene as a potential therapeutic target in small bowel adenocarcinoma.

D. Aust, P. Laurent-Puig, H. Blons, 2014, European journal of cancer.

Recurrent inactivating mutations of ARID2 in non‐small cell lung carcinoma

S. Imbeaud, J. Zucman‐Rossi, E. Letouzé, 2013, International journal of cancer.

Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples.

P. Laurent-Puig, A. Cazes, H. Blons, 2012, Experimental and molecular pathology.

Different prognostic impact of STK11 mutations in non-squamous non-small-cell lung cancer

P. Laurent-Puig, M. Riquet, H. Blons, 2015, Oncotarget.